Norethis NCR (Norethisterone Acetate Controlled Release 10mg) Tablets: Verified Pharmaceutical Exporter from India | Bulk Supplier for USA, UK, Australia, Thailand, Singapore & Jamaica

Product Profile: Norethis NCR (Norethisterone Acetate Controlled Release 10mg)

Norethis NCR is a specialized high-dose, controlled-release formulation of Norethisterone Acetate (10mg). This dosage and release profile are designed for clinical conditions requiring sustained, therapeutic progestogenic levels for longer durations, effectively managing complex gynecological disorders.

1. Clinical Indications & Usage

Severe Endometriosis: Indicated for the management of severe, symptomatic endometriosis where continuous progestogenic suppression is required to inhibit endometrial tissue growth.

Complex Menstrual Disorders: Used for the treatment of intractable dysfunctional uterine bleeding and heavy menstrual loss where standard dosing is insufficient.

Secondary Amenorrhea: Utilized in protocols to induce withdrawal bleeding in cases of profound hormonal deficiency or persistent cycles of non-responsiveness to lower-dose therapies.

Breast Cancer (Palliative): In specific clinical scenarios, high-dose progestogens may be used for the palliative treatment of advanced, hormone-dependent breast cancer in postmenopausal women.

2. Mechanism of Action

Enhanced Suppression: By delivering 10mg of Norethisterone Acetate in a controlled-release matrix, the formulation provides more uniform serum hormone levels, preventing the peaks and troughs associated with conventional tablets. This leads to more effective and predictable suppression of the pituitary-ovarian axis.

Deep Endometrial Atrophy: The sustained delivery promotes a rapid and deep transformation of the endometrium, which is essential for stopping persistent uterine bleeding and atrophy of endometriotic lesions.

Optimized Pharmacokinetics: The controlled-release mechanism ensures a steady state, potentially enhancing patient compliance and therapeutic efficacy for long-term suppressive therapy.

3. Administration and Dosing

Regimen: The 10mg controlled-release dosage is reserved for specific therapeutic protocols. Treatment must be strictly managed by a specialist.

Administration: Tablets must be swallowed whole with water. Do not crush, chew, or split the tablet, as doing so will disrupt the controlled-release delivery system, leading to a sudden release of the drug that may cause adverse reactions or loss of efficacy.

Consistency: Adherence to the daily dosing schedule is critical for maintaining the therapeutic steady state.

⚠️ Safety, Side Effects, and Monitoring

Contraindications: Prohibited in patients with active thromboembolic diseases (DVT, PE), undiagnosed vaginal bleeding, severe liver impairment, known pregnancy, or hormone-sensitive malignancies (unless specified for palliative cancer care).

Common Side Effects: Higher-dose progestogens may result in more pronounced side effects, including significant fluid retention, weight gain, fatigue, breast tenderness, and mood changes (including depression).

Clinical Monitoring: Patients on high-dose therapy require regular monitoring of blood pressure, liver function, and, in long-term therapy, lipid profiles.

📦 Storage, Stability & Commercial Packaging

Storage: Store at room temperature (below 30°C / 86°F).

Protection: Keep in original blister packaging to protect from moisture and light.

Security: Keep securely out of reach of children and others to prevent unauthorized use

PRESCRIPTION MEDICINE IS : YES.

Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Norethis NCR is a high-dose prescription medicine and must be utilized strictly under the direct guidance of a registered medical specialist. All cross-border importing setups must comply with the native health authorities of the destination country.

📞 Contact Ernest Impex — Pharmaceutical Exporter from India

[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]

🌐 Official Websites:

www.ernestimpex.com

www.oncologymedicinesupplier.com

www.ernestpharmaceuticals.com

www.ernestvision.com

📧 Corporate Email: exports@ernestpharmaceuticals.com

📦 Business Type: Exporter | Bulk Supplier | Distributor

📲 WhatsApp: +91 93599 02383

📲 WhatsApp Link: https://wa.me/919359902383